DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Puerarin is an investigational drug.
There have been 6 clinical trials for Puerarin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Arthritis, Rheumatoid, Arthritis, and Alcoholism. The leading clinical trial sponsors are Chengdu PLA General Hospital, Health and Medical Research Fund, Hong Kong, and Cairo University.
Recent Clinical Trials for Puerarin
|Effect of Puerarin on Heart Health in Men||Health and Medical Research Fund, Hong Kong||Phase 2|
|Effect of Puerarin on Heart Health in Men||The University of Hong Kong||Phase 2|
|Alveolar Cleft Grafting Using Two Different Alloplastic Grafts||Cairo University||Phase 2|